Sensitivity of flow cytometric assay for measurement of human intracellular heat shock protein 27

Journal of Immunoassay and Immunochemistry

Volumn 28, Issue 3, 2007, Pages 189-198

  De, Asit K ^a   Strickland, Jennifer ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Flow cytometry; Hsp27; Human; Sensitivity; Western blotting

Indexed keywords

CELL PROTEIN; HEAT SHOCK PROTEIN 27;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKEMIA; LEUKEMIA CELL LINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HUMANS; JURKAT CELLS; SENSITIVITY AND SPECIFICITY;

EID: 34347399951     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810701454599     Document Type: Article

References (20)

1. Garrido, C.; Brunet, M.; Didelot, C.; Zermati, Y.; Schmitt, E.; Kroemer, G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell. Cycle 2006, 5, 2592-2601.
2. Schmitt, E.; Gehrmann, M.; Brunet, M.; Multhoff, G.; Garrido, C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J. Leukoc. Biol. 2007, 81, 15-27.
3. Parcellier, A.; Schmitt, E.; Brunet, M.; Hammann, A.; Solary, E.; Garrido, C. Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions. Antiox. Redox Signal. 2005, 7, 404-413.
4. Oya-Ito, T.; Liu, B.F.; Nagaraj, R.H. Effect of methylglyoxal modification and phosphorylation on the chaperone and anti-apoptotic properties of heat shock protein 27. J. Cell. Biochem. 2006, 99, 279-291.
5. Oesterreich, S.; Weng, C.; Qiu, M.; Hilsenbeck, S.G.; Osborne, C.K. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res. 1993, 53, 4443-4448.
6. Hansen, R.; Parra, I.; Lemieux, P.; Oesterreich, S.; Hilsenbeck, S.; Fuqua, S. Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res. Treat. 1999, 56, 185-194.
7. Vargas-Roig, L.M.; Gago, F.E.; Tello, O.; Aznar, J.C.; Ciocca, D.R. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Intl. J. Cancer 1998, 79, 468-475.
8. Lee, J.H.; Sun, D.; Cho, K.J.; Kim, M.S.; Hong, M.H.; Kim, I.K.; Lee, J.S.; Lee, J.H. Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay. J. Cancer Res. Clin. Oncol. 2007, 133, 37-46.
9. Ciocca, D.R.; Calderwood, S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10, 86-103.
10. Ioachim, E.; Tsanou, E.; Briasoulis, E.; Batsis, C.; Karavasilis, V.; Charchanti, A.; Pavlidis, N.; Agnantis, N.J. Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer. Breast 2003, 12, 111-119.
11. Oesterreich, S.; Hilsenbeck, S.G.; Ciocca, D.R.; Allred, D.C.; Clark, G.M.; Chamness, G.C.; Osborne, C.K.; Fuqua, S.A. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. Clin. Cancer Res. 1996, 2, 1199-1206.
12. Love, S.; King, R.J. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Brit. J. Cancer 1994, 69, 743-748.
13. Thanner, F.; Sutterlin, M.W.; Kapp, M.; Rieger, L.; Morr, A.K.; Kristen, P.; Dietl, J.; Gassel, A.M.; Muller, T. Heat shock protein 27 is associated with decreased survival in node-negative breast cancer patients. Anticancer Res. 2005, 25, 1649-1653.
14. Ciocca, D.R.; Green, S.; Elledge, R.M.; Clark, G.M.; Pugh, R.; Ravdin, P.; Lew, D.; Martino, S.; Osborne, C.K. Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study). Clin. Cancer Res. 1998, 4, 1263-1266.
15. Teimourian, S.; Jalal, R.; Sohrabpour, M.; Goliaei, B. Down-regulation of hsp27 radiosensitizes human prostate cancer cells. Intl. J. Urol. 2006, 13, 1221-1225.
16. De, A.; Roach, S. Detection of the soluble heat shock protein 27 (hsp27) in human serum by an ELISA. J. Immunoassay Immunochem. 2004, 25, 159-170.
17. De, A.K.; Kodys, K.M.; Yeh, B.S.; Miller-Graziano, C. Exaggerated human monocyte IL-10 concomitant to minimal TNF-α induction by heat shock protein 27 (hsp27) suggests hsp27 is primarily an antiinflammatory stimulus. J. Immunol. 2000, 165, 3951-3958.
18. Takahashi, S.; Narimatsu, E.; Asanuma, H.; Okazaki, M.; Okazaki, A.; Hirata, K.; Mori, M.; Chiba, T.; Sato, N.; Kikuchi, K. Immunohistochemical detection of estrogen receptor in invasive human breast cancer: correlation with heat shock proteins, pS2 and oncogene products. Oncol. 1995, 52, 371-375.
19. Oesterreich, S.; Hickey, E.; Weber, L.; Fuqua, S. Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells. Biochem. Biophys. Res. Comm. 1996, 222, 155-163.
20. Kuang, W.W.; Thompson, D.A.; Hoch, R.V.; Weigel, R.J. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res. 1998, 26, 1116-1123.